1932

Abstract

As the current paradigms of drug discovery evolve, it has become clear that a more comprehensive understanding of the interactions between small molecules and organismal biology will be vital. The zebrafish is emerging as a complement to existing in vitro technologies and established preclinical in vivo models that can be scaled for high-throughput. In this review, we highlight the current status of zebrafish toxicology studies, identify potential future niches for the model in the drug development pipeline, and define the hurdles that must be overcome as zebrafish technologies are refined for systematic toxicology.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-pharmtox-010611-134751
2012-02-10
2024-04-20
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-pharmtox-010611-134751
Loading
/content/journals/10.1146/annurev-pharmtox-010611-134751
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error